2026 Urogynecology for the Advanced Practice Provider-Medical Weight Management

Video Transcription

Video Summary

Dr. Jenna Sarvadio, an endocrinology professor and program director, presented a medical weight management talk focused on obesity’s medical contributors and treatment options. She reviewed how hypothyroidism, Cushing syndrome, and diabetes can coexist with and worsen weight gain, and emphasized appropriate screening tests: TSH for hypothyroidism, cortisol-based tests for Cushing syndrome, and glucose/A1c testing for diabetes.<br /><br />She then covered FDA-approved anti-obesity medications, including phentermine, phentermine/topiramate, naltrexone/bupropion, semaglutide, tirzepatide, and orforglipron. She explained that medication choice should be based on comorbidities, patient preference, and insurance coverage. Semaglutide and tirzepatide were highlighted as the most effective therapies, with tirzepatide producing the greatest average weight loss. Common side effects include nausea, constipation, diarrhea, and delayed gastric emptying, which can affect anesthesia planning. She also reviewed current guidance suggesting risk-based management and often a liquid diet before procedures for patients on GLP-1 drugs.<br /><br />The talk ended by stressing that lifestyle change remains essential, especially in perimenopausal women, and that preserving muscle mass through adequate protein, hydration, and strength training is important. Audience questions focused on lean muscle loss and real-world use of GLP-1 medications, especially in older adults and cosmetic-medspa settings.

Asset Subtitle

Today, medical weight loss goes beyond diet and exercise. Medical treatments can support sustainable weight loss and improve health outcomes.

Learning Objectives:

Screen for conditions like hypothyroidism, Cushing’s syndrome, and diabetes, which may coexist and contribute to obesity.
Understand the role of FDA-approved weight loss medications and when they are appropriate.
Discover how individualized diet, exercise, and medication plans can be applied to perimenopausal women

Speaker: Jenna Sarvaideo, DO

Keywords

obesity

endocrinology

weight management

hypothyroidism

Cushing syndrome

diabetes

GLP-1 medications

tirzepatide